key: cord-1055129-pa8r29nm
authors: Zhang, Jianguo; Ding, Daoyin; Huang, Xing; Zhang, Jinhui; Chen, Deyu; Fu, Peiwen; Shi, Yinghong; Xu, Wenrong; Tao, Zhimin
title: Differentiation of COVID‐19 from seasonal influenza: a multicenter comparative study
date: 2020-08-28
journal: J Med Virol
DOI: 10.1002/jmv.26469
sha: 9e010ce71d1373ed60dd22936661e04156606046
doc_id: 1055129
cord_uid: pa8r29nm

OBJECTIVE: As coronavirus disease 2019 (COVID‐19) crashed into the influenza season, clinical characteristics of both infectious diseases were compared to make a difference. METHODS: We reported 211 COVID‐19 patients and 115 influenza patients as two separate cohorts at different locations. Demographic data, medical history, laboratory findings, and radiological characters were summarized and compared between two cohorts, as well as between patients at the Intensive Care Unit (ICU) and non‐ICU within the COVID‐19 cohort. RESULTS: For all 326 patients, the median age was 57.0 (IQR 45.0‐69.0) and 48.2% was male, while 43.9% had comorbidities that included hypertension, diabetes, bronchitis, and heart diseases. Patients had cough (75.5%), fever (69.3%), expectoration (41.1%), dyspnea (19.3%), chest pain (18.7%) and fatigue (16.0%), etc. Both viral infections caused substantial blood abnormality, whereas the COVID‐19 cohort showed a lower frequency of leukocytosis, neutrophilia or lymphocytopenia, but a higher chance of creatine kinase elevation. 7.7% of all patients possessed no abnormal sign in chest CT scans. For both infections, pulmonary lesions in radiological findings did not show any difference in their location or distribution. Nevertheless, compared to the influenza cohort, the COVID‐19 cohort presented more diversity in CT features, where certain specific CT patterns showed significantly more frequency, including consolidation, crazy paving pattern, rounded opacities, air bronchogram, tree‐in‐bud sign, interlobular septal thickening, and bronchiolar wall thickening. CONCLUSION: Differentiable clinical manifestations and CT patterns may help diagnose COVID‐19 from influenza and gain a better understanding of both contagious respiratory illnesses. This article is protected by copyright. All rights reserved.

Induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel pneumonia emerged in the Hubei Province of China on last December, which was later classified as coronavirus disease 2019 (COVID-19). [1] [2] [3] This SARS-CoV-2 was genetically identified with an identity of >96% to RaTG13, suggesting its zoonotic origin from bat. 4 COVID-19 proves to be one highly contagious disease that enables human transmissions with a reproductive value of 1.9-2.2. 1, 5 As of June 7, 2020, This article is protected by copyright. All rights reserved. Accepted Article over 6 million cases of COVID-19 infection were confirmed with global death toll near 400,000. 6 COVID-19 resembles influenza-like illness, with symptoms typified by fever, cough, and fatigue, etc. [7] [8] [9] Coincidentally, COVID-19 pandemic overlaps with influenza season, posing double threats to public health and complicating the disease diagnosis and management. With avian origin, two major types of influenza viruses (i.e., influenza A and B) annually circulate among humans with a variety of subtype mutants, inducing mild to severe illness, where the highly pathogenic strains of influenza A, such as H1N1 and H7N9, have caused substantial mortality during recent outbreaks. 10 Besides, influenza C virus might induce mild symptoms in children while influenza D virus only circulated between animals. 11 With the median reproductive value of 1.28, 5-15% world population is infected with seasonal influenza each year, leading to death toll of half million. 10, 12 Both COVID-19 and influenza can be diagnosed by nucleic acid detection in sputum samples or nasal/throat swabs, or antibody detection through serological testing. 11, 13 However, the accuracy of antigen detection mostly depends on viral loads in the sample collection, sometime resulting in false negativity, whereas the sensitivity of antibody tests is still in need of improvement, avoiding false positivity owing to cross-reactivity. Therefore, This article is protected by copyright. All rights reserved. 

influenza A virus (H1N1 and H3N2), 71 (61.7%) with influenza B, and among them 66 (57.4%) were co-infected. Influenza patients were hospitalized at TAHJU, where oxygen therapy was applied along with ribavirin or oseltamivir antiviral treatment, and none of them developed into critically ill or fatal conditions. Upon admission, influenza patients had been hospitalized for 7-10 days.

The categorical variables were described as frequency rates and percentages, and continuous variables were applied to describe the median and quartile range (IQR) values. Comparison of continuous variables between two groups was analyzed with Mann-Whitney test.

Repeated measurements (non-normal distribution) were used following a generalized linear mixed model. χ 2 test was used to compare the proportion of categorical variables, and the Fisher exact test was employed when data was limited. All statistical analyses were performed using GraphPad Prism 5.0 software (GraphPad Software, Inc., San Diego, CA). A two-sided α of less than 0.05 was considered statistically significant unless otherwise specified.

This article is protected by copyright. All rights reserved. Figure 1A ). Other noted comorbidities were listed in Table S1 .

Despite different viral infections, the common symptoms included cough, fever, expectoration, dyspnea, chest pain and fatigue, etc. (Table 1 and Figure 1B ). Notably, a significantly higher portion of influenza cohort experienced expectoration, chest pain and vomiting than COVID-19 cohort.

Baseline blood parameters were tested for COVID-19 and influenza patients upon hospitalization (Table 1) . Both viral infections caused blood abnormality in a substantial part of patients, leading to aberrant blood cell counts and elevated hepatic/renal/cardiac enzyme activity. Among them, lower frequency of leukocytosis, neutrophilia or lymphocytopenia but higher incident of deranged creatine kinases could be found with significance in COVID-19 cohort than that in influenza cohort ( Figure 1C ).

Upon hospital admission, CT scans were performed for all patients ( Figure 2A ). For both infections, bilateral lung involvement was found a This article is protected by copyright. All rights reserved.

much higher incident than unilateral lung involvement (71.2% vs. 21.2%).

The lesions tended to locate in the peripheral rather than the central area (39.9% vs. 10.7%), but the peripheral lesions mixed with the central ones were mostly observed in CT findings ( Figure 2B ). Both viruses were inclined to infect different lobes in an order following right lower (lobe) We next examined radiological features in all patients by investigating each characteristic CT pattern (Table 2 and Figure S1 ). Frequency of one specific CT pattern was calculated for either COVID-19 or influenza cohort and plotted versus each other ( Figure 2B ). In general, COVID-19 group showed higher diversity in characteristic CT patterns than influenza group, suggesting more complicated pulmonary pathogenesis induced by SARS-CoV-2. Compared to influenza cohort, COVID-19 cohort presented This article is protected by copyright. All rights reserved.

those imaging features more frequently with significance (P<0.05), including consolidation, crazy paving pattern, rounded opacities, air bronchogram, tree-in-bud sign, interlobular septal thickening, and bronchiolar wall thickening.

In this study, influenza patients developed mild to moderate symptoms upon hospital admission, but none of severe or fatal cases was recorded. 

binding, camostat mesylate to block TMPRSS2, (hydroxy)chloroquine to stop viral entry, and remdesivir/favipiravir to halt viral replication. 20 In contrast, influenza A or B virus has a membrane envelope of bilayer lipids, outside which protrude two important surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). 10 Enclosed were viral proteins together with eight negative-sense single-stranded RNA segments. 11 When infecting, HA first directs the specific binding to sialic acid with α2,6-linkage to oligosaccharide on the host cell surface, being entrapped into endosomes via endocytosis where later acidification promotes viral membrane fusion. 10,21 NA then breaks down the bond between HA and sialic acid, releasing viral proteins and RNAs into cytoplasm of host cells. 21 Negative-sense single-stranded RNAs of influenza virus relocate into nucleus for conversion into positive-stranded mRNAs that later return to cytosols for syntheses of viral proteins, followed by re-assembly of viral components and budding of new virions. 11 Viral RNA segments that encode HA and NA could undergo genetic assortments when two co-infected influenza viruses of the same type could switch their viral RNA genomes, forming a diversity of antigenically different virus strains. 11 Recently, a new genotype 4 influenza virus was identified due to reassortment of an avian virus and two strains of H1N1, allegedly This article is protected by copyright. All rights reserved.

holding pandemic potentials. 22 Hence, variable HA and NA are main objectives in vaccine designing for seasonal influenza immunization.

Oseltamivir (oral) and zanamivir (inhaled) are effective medications against influenza by blocking NA. 23 Once infected, most COVD-19 and influenza patients had clinical symptoms, predominantly showing cough, fever, and to a lesser extent, expectoration, dyspnea, and chest pain, etc. Among them, COVID-19 cohort exhibited a much higher portion of patients that experienced less productive coughing without expectorating. It inferred that despite of both infections lining the human airways, SARS-CoV-2 became more inclined to accumulate in the deep lungs, causing further pulmonary damages.

Noticeably, both viral infections impinged on gastrointestinal systems, inducing diarrhea, abdominal pain, and vomiting, as well as cardiovascular functions, prompting dyspnea and chest pain.

Hospitalized influenza cohort showed a higher age than COVID-19 one, owing to a fact that young influenza patients usually developed mild symptoms with no medical attention or care given. Most comorbidities for influenza cohort showed higher frequency than COVID-19 cohort, possibly associated with the higher age of patients. Consistent with previous reports, senior COVID-19 patients with underlying conditions, especially This article is protected by copyright. All rights reserved.

hypertension, diabetes and cardiovascular diseases as the leading co-morbidity, became more susceptible to disease contraction and severity. [7] [8] [9] Concerns that medications on those chronic diseases might upregulate the ACE2 expression and heighten the infection risk have been argued with no provable grounds. 24 In addition, being a chronic obstructive lung disease, bronchitis remains one of major comorbidities for influenza patients, but a less risk factor for COVID-19. This could be associated with [26] [27] [28] However, for certain specific CT patterns, COVID-19 cohort was observed with significantly higher frequency than influenza cohort, including consolidation, crazy paving pattern, rounded opacities, air bronchogram, tree-in-bud sign, interlobular septal thickening, and bronchiolar wall thickening. Furthermore, in COVID-19 cohort, ICU patients exhibited more frequently in consolidation, crazy paving pattern, rounded opacities, halo sign and pleural effusion when compared to non-ICU group, mirroring a changed CT feature as the disease condition was aggravated.

Put together, albeit disease profiles of both viral infections share many in common, differentiable clinical manifestations and CT patterns could This article is protected by copyright. All rights reserved.

help diagnose COVID-19 from influenza and deepen our understanding of both contagious respiratory illnesses.

We are grateful for the financial support by Jiangsu University.

The authors declare no conflict of interest.

JiaZ, DD, XH, and ZT conceived the idea, designed the study, and had approved access to all data. JiaZ, DC, YS, WX and ZT contributed to the manuscript writing. PF and ZT contributed to the figure preparation. JiaZ, DD, XH, JinZ and ZT contributed to the statistical analysis. All authors contributed to data analysis, and all reviewed and approved the manuscript submission.

Data available on request due to privacy/ethical restrictions. Diagonal line (dotted) indicated a hypothetically equal frequency between the two cohorts. Arrows pointed to those that were partially overlapped or specifically indicated.

Representative CT images were shown for both infections. For COVID-19 patient, one 64-year-old woman with fever of 5 days (upper left). Axial CT image showed ground-glass opacities (GGOs) and nodules, and lesions were mainly in left lower lobe with central distribution. Another 61-year-old man with fever of 6 days (upper right). Axial CT image showed GGOs and consolidation, and lesions were mainly in right lobes and peripherally distributed. For influenza patients, one 85-year-old man with fever, cough, and sputum of 7 days (lower left). Axial CT images showed GGOs in left lower lobe and consolidation in right lobe. Another 66-year-old man with cough and fever of 7 days (lower right). Axial CT images showed GGOs in right lower lobe, and lesions were peripherally distributed. (B) Frequency of each specific CT pattern in COVID-19 cohort was plotted versus that in influenza cohort. Diagonal line (dotted) indicated a hypothetically equal frequency between the two cohorts.

outer protein shell that encapsulates gRNAs (purple) and nucleoproteins, with a mixed coverage of M (pink), S (light brown), and E (teal) proteins. It binds to cell surface (lower part) rich of ACE2 (red) expression through a receptor-mediated endocytosis (in close view), for intercellular trafficking and unleashing of genetic materials to replicate at ribosome, reassemble at Golgi apparatus, and finally end up with exocytosis. (Right) Influenza A virus has an envelope of bilayer lipids (tan) with HA (green) and NA (mustard) on surface, and enclosed were eight gRNA segments (magenta). When influenza virus attacks, HA binds to sialic acid on the host cell surface (in close view), being engulfed into endosomes. gRNAs were then liberated to enter nucleus for synthesis of mRNAs, being transported to cytoplasm to produce viral proteins, followed by reassembly and budding of new virions for exocytosis 11 . 

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

A Novel Coronavirus from Patients with Pneumonia in China

Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

Coronavirus disease 2019 (COVID-19): situation report

Clinical Characteristics of 138 Hospitalized Patients With

Novel Coronavirus-Infected Pneumonia in Wuhan

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical Characteristics of Coronavirus Disease 2019 in China

The evolution of seasonal influenza viruses

Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature

Diagnosing COVID-19: The Disease and Tools for Detection

Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Structure, function, and evolution of coronavirus spike proteins. Annual review of virology

SARS-CoV-2 Cell Entry Depends on 18

Coronavirus infection, ER stress, apoptosis and innate immunity

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

Structure, function and evolution of the hemagglutinin-esterase proteins of corona-and toroviruses

Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection

Drugs for Influenza Treatment: Is There Significant News? Front Med (Lausanne)

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia

Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias